Prescription Required
It is unsafe to consume alcohol with Eurepa MF 2 Tablet.
Eurepa MF 2 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Eurepa MF 2 Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Eurepa MF 2 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Eurepa MF 2 Tablet may be needed. Please consult your doctor.<BR>Use of Eurepa MF 2 Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Eurepa MF 2 Tablet should be used with caution in patients with liver disease. Dose adjustment of Eurepa MF 2 Tablet may be needed. Please consult your doctor.<BR>Eurepa MF 2 Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Eurepa MF 2 Tablet is a combination of two antidiabetic medicines: Repaglinide and metformin. Repaglinide is a meglitinide analogue which increases the amount of insulin released by the pancreas. This prevents blood glucose from rising very high after meals. Metformin is a biguanide which decreases the production and absorption of sugar in your body and allows better use of existing insulin. Together, they provide better control of blood sugar.
Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA